Home » Merck Submits Application to Extend Indication of MS Drug Rebif in Europe
Merck Submits Application to Extend Indication of MS Drug Rebif in Europe
German pharmaceutical and chemicals company Merck KGaA said it has submitted an application to the EMA to extend indication of its multiple sclerosis or MS drug Rebif.
RTT News
RTT News
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May